Augmedix, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 12.68 million compared to USD 8.75 million a year ago. Net loss was USD 4.49 million compared to USD 5.6 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | -4.27% | -8.94% | -80.85% |
May. 14 | Maxim Downgrades Augmedix to Hold From Buy | MT |
May. 14 | B. Riley Adjusts Price Target on Augmedix to $3 From $5.50, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.85% | 57.03M | |
+15.50% | 71.21B | |
+6.72% | 17.26B | |
+11.94% | 13.96B | |
+21.12% | 13.54B | |
+16.67% | 10.13B | |
-21.17% | 7.05B | |
-2.54% | 6.17B | |
+2.69% | 5.22B | |
+0.32% | 5.06B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023